Showing results (771-780 of 1,615) with videos related to
Sort By:
Pageof 162
Cancer Journal (Sudbury, Mass.)|September 26, 2012
Chemotherapy alone for localized diffuse large B-cell lymphomaLaurie H SehnCancer Journal (Sudbury, Mass.)|September 26, 2012
Management of the cutaneous peripheral T-cell lymphomas: when subtypes matterMichael Youngjun Choi, Mary Jo LechowiczCancer Journal (Sudbury, Mass.)|September 26, 2012
Nonmyeloablative allogeneic stem cell transplantation for non-hodgkin lymphomaIssa F Khouri, Richard E ChamplinCancer Journal (Sudbury, Mass.)|September 27, 2021
Neurosurgical Advances for Malignant Gliomas: Intersection of Biology and TechnologyYosef Dastagirzada, Carter Suryadevara, Hannah Weiss, et al.Cancer Journal (Sudbury, Mass.)|September 27, 2021
Therapeutic Response Assessment of High-Grade Gliomas During Early-Phase Drug Development in the Era of Molecular and ImmunotherapiesBenjamin M Ellingson, Patrick Y Wen, Timothy F CloughesyCancer Journal (Sudbury, Mass.)|May 17, 2023
Updates in Classification of Myelodysplastic SyndromeMina L Xu, Robert P HasserjianCancer Journal (Sudbury, Mass.)|May 17, 2023
Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid NeoplasmsZhuoer Xie, Evan C Chen, Lourdes M Mendez, et al.Cancer Journal (Sudbury, Mass.)|May 17, 2023
Germline Predisposition to Myelodysplastic SyndromesGeorgina Gener-Ricos, Yoheved S Gerstein, Danielle Hammond, et al.Cancer Journal (Sudbury, Mass.)|May 17, 2023
Novel Therapies in Myelodysplastic Syndrome: Where Do Venetoclax and Isocitrate Dehydrogenase Inhibitors Fit in?Yasmin Abaza, Anand Ashwin PatelCancer Journal (Sudbury, Mass.)|January 22, 2014
Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogramCaroline Sweldens, Stephanie Peeters, Erik van Limbergen, et al.Pageof 162